Skip to main content
LIPID MAPS®
menu
Databases
LMSD
LMPD
COMP_DB
LMISSD
Ion Mobility
Partial Spectra DB
Standards Spectra DB
Oxidized Phospholipid DB
Shorthand DB
Pathways
Reactions Explorer
LIPID MAPS® Pathways
SphinGOMAP©
Cayman Pathway Maps
Tools
Lipidomics
Tool Guide
MS Analysis
Structure
Drawing
Statistical
Analysis
Nomenclature
Tools
Lipid Analysis
Software
Education
Webinars
Podcasts
Tutorials
Resources
Classification
Nomenclature
Structure
Methods and
Protocols
Training
School
Community
Lipid of the
Month
Lipid Matters
Blog
Highlights
LipidWeb
Newsletters
External
Resources
Events Calendar
About
About Us
About Our
Partners
About Our
Sponsors
Sponsor Us
Contact Us
Archive
Downloads
Downloads Hub (All)
Experimental Data
REST
SPARQL
LMSD
LMPD
COMP_DB
PARTIAL_DB
Standards Spectra DB
login
Login
Microarray analysis of bone marrow-derived macrophage cells treated with Kdo
2
-lipid A (KLA) and ATP
Search by fold change ratio
|
Search by KEGG pathway
|
Search by LIPID MAPS lipid pathway
Kdo
2
-Lipid A / ATP gene array data - treatment:control ratios
KEGG pathway: Carbohydrate digestion and absorption (mmu04973)
Legend:
: View data/graphs for replicates
Gene symbol  
Time course plot
Accession
Description
Treatment
15min
30min
1hr
2hr
4hr
8hr
20hr
2010204N
08Rik
KLA
ATP
ATP+KLA
NM_001081137
RIKEN cDNA 2010204N08 gene (2010204N08Rik), mRNA [NM_001081137]
KLA
.99
.98
1.00
.96
.98
.98
.99
ATP
.96
.98
1.06
1.14
.98
.97
.99
KLA/ATP
.98
1.05
1.06
1.04
.99
.98
1.94
AK078587
KLA
ATP
ATP+KLA
AK078587
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587]
KLA
1.37
1.28
1.13
1.06
1.15
1.31
1.22
ATP
1.04
1.08
1.21
1.22
1.27
1.12
1.14
KLA/ATP
1.48
1.66
1.97
1.26
1.17
1.03
1.28
Akt1
KLA
ATP
ATP+KLA
NM_009652
thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652]
KLA
.80
.80
.75
.75
.71
.70
.82
ATP
1.00
1.02
.76
.85
.76
.68
.84
KLA/ATP
.82
.80
.64
.68
.67
.61
.72
Akt2
KLA
ATP
ATP+KLA
NM_007434
thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434]
KLA
1.45
1.49
1.81
1.61
1.83
1.17
.92
ATP
1.12
1.12
1.00
1.28
1.20
.94
1.06
KLA/ATP
1.48
1.70
1.69
1.58
1.57
1.32
1.27
Akt3
KLA
ATP
ATP+KLA
NM_011785
thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785]
KLA
3.42
3.45
5.31
5.16
4.65
3.80
2.12
ATP
1.12
1.22
1.10
1.37
1.02
1.11
1.56
KLA/ATP
3.72
4.17
4.62
4.64
2.74
2.05
3.82
Amy1
KLA
ATP
ATP+KLA
NM_007446
amylase 1, salivary (Amy1), transcript variant 1, mRNA [NM_007446]
KLA
1.03
1.01
1.14
1.07
1.06
1.13
1.16
ATP
.99
.98
1.08
1.06
1.09
1.18
1.11
KLA/ATP
1.06
1.10
1.19
1.13
1.16
1.43
1.21
Atp1a1
KLA
ATP
ATP+KLA
NM_144900
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900]
KLA
.78
.94
.68
.81
.62
.55
.75
ATP
1.02
1.05
.86
.85
1.77
2.54
1.11
KLA/ATP
.83
.99
.80
.75
.91
1.15
.68
Atp1a2
KLA
ATP
ATP+KLA
NM_178405
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405]
KLA
1.03
.98
1.03
1.05
1.03
.98
1.02
ATP
1.03
.98
1.06
1.05
1.05
.93
1.07
KLA/ATP
1.04
1.05
1.02
1.02
.98
.92
1.02
Atp1a3
KLA
ATP
ATP+KLA
AK053751
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751]
KLA
.88
.87
.74
.80
.84
.88
.93
ATP
.96
.83
.80
.88
.94
.89
1.15
KLA/ATP
.89
.86
.79
.90
.93
.84
.92
Atp1a3
KLA
ATP
ATP+KLA
NM_144921
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921]
KLA
.99
.87
.96
.86
.81
.61
.52
ATP
1.22
1.21
1.16
1.38
1.27
.92
1.30
KLA/ATP
.96
1.10
1.17
1.42
1.11
.91
.93
Atp1b1
KLA
ATP
ATP+KLA
NM_009721
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721]
KLA
.97
1.02
1.08
.98
.95
1.01
1.09
ATP
1.07
1.05
1.09
1.09
1.02
1.17
1.11
KLA/ATP
.99
.99
.93
1.02
1.00
1.07
1.04
Atp1b2
KLA
ATP
ATP+KLA
NM_013415
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415]
KLA
1.18
1.09
1.11
1.12
1.16
1.12
1.15
ATP
.95
.98
.99
1.26
1.06
1.10
1.07
KLA/ATP
1.15
1.16
1.09
1.19
1.27
1.13
1.02
Atp1b3
KLA
ATP
ATP+KLA
NM_007502
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502]
KLA
1.86
2.10
2.25
2.21
2.68
3.26
3.45
ATP
1.08
1.09
.93
1.13
1.55
2.14
2.38
KLA/ATP
1.95
2.10
1.84
2.34
2.20
2.96
4.69
Atp1b4
KLA
ATP
ATP+KLA
NM_133690
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690]
KLA
.99
1.02
1.03
1.01
.95
.90
1.00
ATP
1.00
1.05
1.04
.98
1.07
.98
.97
KLA/ATP
1.00
1.05
1.03
1.04
.96
.97
1.01
Cacna1d
KLA
ATP
ATP+KLA
NM_001083616
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616]
KLA
1.57
1.58
2.50
3.62
4.55
2.93
.99
ATP
1.12
.99
.97
.94
.75
1.71
1.48
KLA/ATP
1.47
1.51
1.82
1.56
1.67
2.93
4.60
Cacna1d
KLA
ATP
ATP+KLA
NM_028981
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981]
KLA
1.20
1.26
1.43
1.62
2.07
1.66
1.00
ATP
1.03
1.03
.97
.97
.93
1.20
1.26
KLA/ATP
1.16
1.12
1.10
1.14
1.08
1.44
2.56
Fxyd2
KLA
ATP
ATP+KLA
NM_052823
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823]
KLA
1.07
.97
1.09
.98
1.02
.96
.83
ATP
1.07
1.22
1.00
1.14
1.00
1.22
4.11
KLA/ATP
1.06
1.11
.96
1.13
.98
1.01
1.02
G6pc
KLA
ATP
ATP+KLA
NM_008061
glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061]
KLA
.96
.94
1.04
1.07
1.09
1.06
1.02
ATP
.98
1.05
1.09
1.04
1.05
1.00
1.01
KLA/ATP
1.03
1.05
1.06
.96
1.02
1.00
.99
G6pc2
KLA
ATP
ATP+KLA
NM_021331
glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331]
KLA
.99
1.03
1.00
.98
.95
1.02
.98
ATP
.95
1.06
.97
1.08
1.16
1.26
1.04
KLA/ATP
.94
.99
1.05
6.99
3.55
1.48
1.11
G6pc3
KLA
ATP
ATP+KLA
NM_175935
glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935]
KLA
.88
.89
.89
.80
.75
.68
.88
ATP
.99
1.05
.95
1.14
.92
.64
.81
KLA/ATP
.92
.90
.79
.94
.70
.62
.58
Hk1
KLA
ATP
ATP+KLA
J05277
gb|Mouse hexokinase mRNA, complete cds [J05277]
KLA
1.49
1.45
1.66
1.78
1.51
1.29
.99
ATP
1.11
1.05
1.15
1.20
2.31
2.17
1.09
KLA/ATP
1.63
1.51
1.70
1.47
1.94
1.92
1.40
Hk1
KLA
ATP
ATP+KLA
NM_010438
hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438]
KLA
1.58
1.75
2.05
1.84
1.96
1.67
1.31
ATP
1.06
1.25
1.01
1.49
2.23
1.79
1.20
KLA/ATP
1.87
1.96
1.51
1.93
1.71
1.94
1.72
Hk2
KLA
ATP
ATP+KLA
NM_013820
hexokinase 2 (Hk2), mRNA [NM_013820]
KLA
4.09
4.09
3.17
2.37
1.53
1.62
2.02
ATP
.98
.92
1.08
2.24
3.82
3.86
.97
KLA/ATP
4.07
3.94
4.17
3.53
5.42
4.65
1.54
Hk3
KLA
ATP
ATP+KLA
NM_001033245
hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245]
KLA
1.52
1.68
1.94
1.85
2.21
2.89
1.98
ATP
1.01
1.07
.87
.99
1.01
1.26
2.62
KLA/ATP
1.63
1.74
1.67
1.69
1.44
2.01
3.53
Hkdc1
KLA
ATP
ATP+KLA
NM_145419
hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419]
KLA
1.10
1.08
1.12
1.12
1.02
1.07
1.04
ATP
.96
1.04
1.06
4.28
10.50
3.91
1.34
KLA/ATP
.98
1.04
1.14
5.33
12.44
8.68
1.77
Lct
KLA
ATP
ATP+KLA
NM_001081078
lactase (Lct), mRNA [NM_001081078]
KLA
.93
.83
.71
.83
.89
.99
.84
ATP
1.03
.98
.86
.92
.82
.85
.85
KLA/ATP
.80
.88
.75
.78
.89
.87
.86
Mgam
KLA
ATP
ATP+KLA
AK033548
adult male colon cDNA, RIKEN full-length enriched library, clone:9030616M21 product:hypothetical protein, full insert sequence. [AK033548]
KLA
1.16
1.20
1.22
1.21
1.01
1.02
1.07
ATP
1.01
1.01
1.11
2.86
5.71
5.58
1.53
KLA/ATP
1.24
1.24
1.29
1.64
3.84
3.69
1.98
Mgam
KLA
ATP
ATP+KLA
XM_001481277
gb|PREDICTED: Mus musculus maltase-glucoamylase (Mgam), mRNA [XM_001481277]
KLA
1.03
1.04
1.03
1.04
.95
.98
1.06
ATP
1.06
.94
1.05
1.42
2.38
2.12
1.16
KLA/ATP
1.10
1.06
1.06
1.15
1.52
1.64
1.20
Mm.21312
8
KLA
ATP
ATP+KLA
141801344
Unknown
KLA
.96
.95
.83
.77
.52
.99
1.32
ATP
.80
.82
1.09
.80
.83
1.19
1.46
KLA/ATP
.78
.92
.98
.62
.71
.94
1.41
Mm.25237
KLA
ATP
ATP+KLA
141802859
Unknown
KLA
1.03
1.07
1.05
1.08
1.02
1.02
1.00
ATP
.98
1.02
.89
.99
.99
1.03
1.09
KLA/ATP
.92
.94
1.11
1.03
1.02
.97
1.09
Mm.25381
9
KLA
ATP
ATP+KLA
118130676
Unknown
KLA
1.81
1.88
1.96
1.62
1.89
2.44
1.56
ATP
.92
.91
1.24
1.01
1.16
2.06
1.95
KLA/ATP
1.62
1.86
1.86
1.41
1.89
2.37
1.97
Mm.26105
4
KLA
ATP
ATP+KLA
124487274
Unknown
KLA
.95
1.04
.97
.98
1.01
.94
1.10
ATP
1.00
1.06
.94
1.07
1.01
1.00
.98
KLA/ATP
1.04
.99
.93
1.01
1.11
1.07
1.04
Mm.26930
KLA
ATP
ATP+KLA
124487296
Unknown
KLA
1.16
1.07
1.03
1.13
1.13
1.32
1.25
ATP
.99
1.00
1.05
1.24
1.38
1.37
1.06
KLA/ATP
1.03
1.16
1.14
1.22
1.32
1.29
1.32
Mm.33401
KLA
ATP
ATP+KLA
149255058
Unknown
KLA
1.03
1.07
1.00
1.03
1.01
1.03
1.06
ATP
1.12
.98
1.12
1.36
2.32
2.03
1.10
KLA/ATP
1.03
1.00
.99
1.21
1.39
1.58
1.20
Pik3ca
KLA
ATP
ATP+KLA
ENSMUST00000108243
ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243]
KLA
1.07
1.01
.91
.90
.98
.96
.86
ATP
1.03
.87
1.12
.63
1.22
1.86
.60
KLA/ATP
1.05
.82
.91
.61
1.17
1.26
.63
Pik3ca
KLA
ATP
ATP+KLA
NM_008839
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839]
KLA
1.15
1.11
1.05
.82
.99
1.03
1.27
ATP
.98
1.00
.79
.75
.96
1.32
1.10
KLA/ATP
1.10
.98
.64
.72
.80
1.20
1.41
Pik3cb
KLA
ATP
ATP+KLA
NM_029094
phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094]
KLA
1.06
1.06
1.03
.73
.68
.98
1.69
ATP
1.04
1.21
.95
1.02
.85
.93
1.73
KLA/ATP
1.15
1.27
.73
.83
.58
.81
1.81
Pik3cd
KLA
ATP
ATP+KLA
NM_008840
phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840]
KLA
2.28
2.42
3.10
4.17
3.35
2.31
1.34
ATP
1.02
.91
.99
.63
.30
.67
.80
KLA/ATP
2.14
2.23
2.70
1.51
1.17
.85
.72
Pik3cd
KLA
ATP
ATP+KLA
U86587
phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587]
KLA
2.21
2.24
3.71
3.17
3.67
2.66
1.48
ATP
1.00
1.03
.93
.96
.46
.75
.97
KLA/ATP
2.27
2.32
1.97
2.02
1.01
.99
.98
Pik3cg
KLA
ATP
ATP+KLA
NM_020272
phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272]
KLA
.53
.53
.61
.64
.97
.86
.79
ATP
1.01
1.13
.88
.89
.52
.53
.53
KLA/ATP
.58
.53
.43
.60
.40
.43
.62
Pik3r1
KLA
ATP
ATP+KLA
NM_001077495
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495]
KLA
1.05
1.07
1.03
1.00
1.01
1.20
.85
ATP
.97
1.02
1.48
1.42
1.76
1.33
1.23
KLA/ATP
1.11
1.12
1.06
1.17
1.24
.99
1.12
Pik3r2
KLA
ATP
ATP+KLA
NM_008841
phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841]
KLA
.50
.50
.48
.43
.46
.66
.75
ATP
.78
.68
.45
.43
.28
.57
1.37
KLA/ATP
.49
.38
.32
.33
.38
.67
1.10
Pik3r3
KLA
ATP
ATP+KLA
NM_181585
phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585]
KLA
1.59
1.49
1.37
1.17
1.05
1.55
1.41
ATP
1.12
1.00
1.33
1.70
2.01
2.37
2.02
KLA/ATP
1.63
1.54
1.58
1.70
2.43
2.68
1.92
Pik3r5
KLA
ATP
ATP+KLA
NM_177320
phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320]
KLA
3.57
3.58
4.16
3.54
4.11
2.59
2.39
ATP
1.08
1.08
.93
1.67
3.11
1.88
1.34
KLA/ATP
3.91
3.70
3.30
3.80
2.70
2.04
3.00
Plcb2
KLA
ATP
ATP+KLA
NM_177568
phospholipase C, beta 2 (Plcb2), mRNA [NM_177568]
KLA
.70
.68
.64
.67
.65
.76
.88
ATP
.95
.94
1.04
.94
.72
.57
1.19
KLA/ATP
.69
.68
.72
.63
.65
.55
.70
Prkcb1
KLA
ATP
ATP+KLA
NM_008855
protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855]
KLA
.92
.95
.93
.78
.77
1.08
1.83
ATP
1.03
1.12
1.09
1.23
.90
2.08
.96
KLA/ATP
.98
.99
.82
.89
.62
1.01
1.08
Slc2a2
KLA
ATP
ATP+KLA
NM_031197
solute carrier family 2 (facilitated glucose transporter), member 2 (Slc2a2), mRNA [NM_031197]
KLA
1.01
1.03
.97
1.00
1.01
1.02
1.04
ATP
1.02
.97
1.07
1.00
1.00
1.03
1.00
KLA/ATP
1.01
1.01
.95
1.00
1.05
1.02
1.01
Slc2a5
KLA
ATP
ATP+KLA
NM_019741
solute carrier family 2 (facilitated glucose transporter), member 5 (Slc2a5), mRNA [NM_019741]
KLA
.96
1.10
1.00
.95
.95
1.03
.95
ATP
.99
1.00
.99
.99
1.28
1.15
.72
KLA/ATP
.94
.94
.87
.91
1.47
1.41
1.00
Slc37a4
KLA
ATP
ATP+KLA
NM_008063
solute carrier family 37 (glucose-6-phosphate transporter), member 4 (Slc37a4), mRNA [NM_008063]
KLA
.61
.53
.54
.63
.64
.84
.82
ATP
.95
.70
.60
.36
.29
.77
.94
KLA/ATP
.53
.49
.46
.32
.33
.52
.72
Slc5a1
KLA
ATP
ATP+KLA
NM_019810
solute carrier family 5 (sodium/glucose cotransporter), member 1 (Slc5a1), mRNA [NM_019810]
KLA
1.02
1.02
1.03
1.04
.99
.93
1.06
ATP
1.03
1.03
1.02
1.05
1.04
.98
.97
KLA/ATP
1.02
.94
1.02
1.03
1.03
1.04
1.02
Tas1r2
KLA
ATP
ATP+KLA
NM_031873
taste receptor, type 1, member 2 (Tas1r2), mRNA [NM_031873]
KLA
.98
.97
1.09
1.07
1.04
1.07
1.11
ATP
.96
1.00
1.06
2.63
2.51
1.41
1.19
KLA/ATP
1.02
1.08
1.11
2.55
2.91
1.76
1.13
Tas1r3
KLA
ATP
ATP+KLA
NM_031872
taste receptor, type 1, member 3 (Tas1r3), mRNA [NM_031872]
KLA
1.11
1.20
1.23
1.21
1.17
1.44
1.13
ATP
1.05
1.07
1.09
1.20
1.07
1.05
1.14
KLA/ATP
1.18
1.18
1.03
1.19
1.18
1.10
1.25